PharmaBoardroom

Year in Review – Transformational Transactions Dominated…

Christoph Bieri, PhD is Managing Partner of Kurmann Partners, an M&A firm advising Pharma and MedTech companies on strategic mid-market deals in…

The Pharmacy in 2019

Meghann Chilcott, Chief Technology/Marketing Officer at Benzer Pharmacy looks at current pharmaceutical service trends that aim to create a more…

“Restricting Drug Patent Settlements is Bad for US…

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the US urges Congress to avoid restricting…

Perspectives from J.P. Morgan’s 2019 Health Care Investor…

Our contributor at large, David Crean, Managing Director for Objective Capital Partners, attended J.P. Morgan's 2019 Health Care Investor…

The Ideal Pharma Country Manager: South Korea (Egon Zehnder)

Examining what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. Here, Eugene Kim,…

Real-World Evidence – A Game Changer for Pharma

Nawal Roy is founder and CEO of Holmusk, a company dedicated to building one of the world’s largest real-world evidence platforms for neurosciences.…

Digital Therapeutics Need the Scrutiny of All Health Stakeholders

Carla Smith is a healthcare thought leader with nearly 30 years' experience. She champions transformational strategy, governance, and policy in the…

Mythbusting: Patient Access to Rare Disease Treatments

After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica founded Bridge the Gap – SYNGAP Education and Research…

Healthcare Politics in 2019

Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In this article, he gives his predictions for the political landscape in…

The Long and Short of Drug Shortages in America

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) weighs in on the issue of drug shortages in…

Precision Medicine Needs Global Genetic Data

Axel Schumacher, co-founder and chief scientific officer of Shivom, a data-driven next generation precision-medicine company in the blockchain space,…

How do we Encourage Patients to Continue Taking their Medicines?

David Peña Castillo, president and founder of the Mexican Federation of Rare Diseases (FEMEXER), addresses the problem of patients deserting…

Tagged with Opinion